HEMP: CBD-induced Biomarkers of Inflammation Reduction in People Living With HIV at the Single Cell Level
Status:
Not yet recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
People living with HIV (PLWH) are affected by comorbidities appearing to be strongly related
to chronic inflammation, a condition characterizing PLWH.
The investigators propose to study the effects of CBD on inflammation in PLWH, and establish
the molecular role of different immune cells in this process. The investigators plan to use
single cell RNA-sequencing (scRNAseq) to isolate CBD-specific cellular phenotypes from five
persons with HIV who will provide blood samples before and after taking CBD.